Hao Liang
Kunming University of Science and Technology(CN)Beihua University(CN)Guizhou Normal University(CN)Peking University(CN)Peking University Third Hospital(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, SARS-CoV-2 and COVID-19 Research, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Generative Adversarial Networks and Image Synthesis
Most-Cited Works
- → Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro(2021)308 cited
- → Roles of meteorological conditions in COVID-19 transmission on a worldwide scale(2020)190 cited
- → Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds(2020)66 cited
- → A novel mutation in the TUBB8 gene is associated with complete cleavage failure in fertilized eggs(2018)60 cited
- → Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease(2021)57 cited
- → Expanding the phenotypic and genetic spectrum of Chinese patients with congenital absence of vas deferens bearing CFTR and ADGRG2 alleles(2019)44 cited